Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS) and reminds investors of the ...

GeneDX recorded a non-GAAP (adjusted) loss of $0.28 per share on sales of roughly $102.3 million in the first quarter. While ...

View GeneDx Holdings Corp. Class A WGS stock quote prices, financial information, real-time forecasts, and company news from CNN.

GeneDx (Nasdaq: WGS) today announced that management will participate in the Goldman Sachs Healthcare Conference from June ...

Activists also report to the SEC on Alkami Technology, Satellogic, and Dynatrace.

GeneDx Holdings Corp. (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today reported its financial results for the fourth quarter and full ...

What's interesting about GeneDx's tumble is that its first-quarter performance was, on the surface, rather good. The figures released Wednesday revealed the DNA testing company managed to boost its ...

GeneDx, which specializes in diagnostics for rare and ultra-rare genetic disorders, is helping to get kids the diagnostic attention they need as part of Diagnosis is Power. Currently, one in 10 ...

In the latest quarter, 5 analysts provided ratings for GeneDx Hldgs (NASDAQ:WGS), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...